CD33 and acute myeloid leukemia: To further study CD33 variants in human AML and validate the findings obtained with RNAseq, we designed transcript-specific primers and used RT-PCR to assess expression of the CD33FL, CD33∆E2, CD33E7a, and CD33∆E2,E7a transcripts in 29 pre-treatment specimens from adults with AML.